نتائج البحث

Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues.

• Authors : Ioannidis I; Department of Chemistry, University of Cyprus, 2109 Nicosia, Cyprus.; Lefkaritis G

Subjects: Scandium*/Scandium*/Scandium*/chemistry ; Radioisotopes*/Radioisotopes*/Radioisotopes*/chemistry ; Radioisotopes*/Radioisotopes*/Radioisotopes*/therapeutic use

• Source: International journal of molecular sciences [Int J Mol Sci] 2024 May 29; Vol. 25 (11). Date of Electronic Publication: 2024 May 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [ 177 Lu]Lu-DOTA-TATE or [ 177 Lu]Lu-DOTA-TATE and [ 90 Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm Center.

• Authors : Durma, Adam Daniel¹ (AUTHOR) ; Saracyn, Marek¹ (AUTHOR); Kołodziej, Maciej¹ (AUTHOR)

• Source: Cancers. Nov2023, Vol. 15 Issue 22, p5466. 21p.

تفاصيل العنوان

Replacing Lu-177 with Tb-161 in DOTA-TATE and PSMA-617 therapy: potential dosimetric implications for activity selection.

• Authors : Verburg, Frederik A.¹ (AUTHOR) ; de Blois, Erik¹ (AUTHOR); Koolen, Stijn^1,2,3 (AUTHOR)

• Source: EJNMMI Physics. 11/10/2023, Vol. 10 Issue 1, p1-6. 6p.

تفاصيل العنوان

Radionuclide Cisternography with [ 64 Cu]Cu-DOTA.

• Authors : Greiser, Julia¹ (AUTHOR) ; Groeber, Sebastian² (AUTHOR) ; Weisheit, Thomas² (AUTHOR)

• Source: Pharmaceuticals (14248247). Sep2023, Vol. 16 Issue 9, p1269. 17p.

تفاصيل العنوان

Preparation of 177 Lu-labeled Nimotuzumab for radioimmunotherapy of EGFR-positive cancers: Comparison of DOTA and CHX-A″-DTPA as bifunctional chelators.

• Authors : Pandey U; Radiopharmaceuticals Division, Bhabha Atomic Research Centre, Mumbai, India.; Bhabha Atomic Research Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.

Subjects: Radioimmunotherapy*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*chemistry ; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*therapeutic use

• Source: Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2019 Apr; Vol. 62 (4), pp. 158-165. Date of Electronic Publication: 2019 Feb 17.Publisher: Wiley Country of Publication: England NLM ID: 7610510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1344

تفاصيل العنوان

Safety and efficacy of targeted alpha therapy with 213 Bi-DOTA-substance P in recurrent glioblastoma.

• Authors : Królicki L; Nuclear Medicine Department, Medical University of Warsaw, ul. Banacha 1 a, 02-097, Warsaw, Poland.; Bruchertseifer F

Subjects: Safety*; Alpha Particles/Alpha Particles/Alpha Particles/*adverse effects ; Alpha Particles/Alpha Particles/Alpha Particles/*therapeutic use

• Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Mar; Vol. 46 (3), pp. 614-622. Date of Electronic Publication: 2018 Nov 29.Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [ 153 Sm]Sm-DOTA-TATE.

• Authors : Vermeulen, Koen¹ (AUTHOR); Van de Voorde, Michiel¹ (AUTHOR); Segers, Charlotte¹ (AUTHOR)

• Source: Pharmaceutics. Dec2022, Vol. 14 Issue 12, p2566. 15p.

تفاصيل العنوان

Novel use of 177 Lu-DOTA-RGD 2 in treatment of 68 Ga-DOTA-RGD 2 -avid lesions in papillary thyroid cancer with TENIS.

• Authors : Parihar AS; Department of Nuclear Medicine, Nehru Hospital, Postgraduate Institute of Medical Education & Research (PGIMER), Ground Floor, A block, Chandigarh, 160012, India.; Sood A

Subjects: Carcinoma, Papillary/Carcinoma, Papillary/Carcinoma, Papillary/*diagnostic imaging ; Carcinoma, Papillary/Carcinoma, Papillary/Carcinoma, Papillary/*radiotherapy ; Heterocyclic Compounds, 1-Ring/Heterocyclic Compounds, 1-Ring/Heterocyclic Compounds, 1-Ring/*chemistry

• Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Sep; Vol. 45 (10), pp. 1836-1837. Date of Electronic Publication: 2018 May 01.Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

Preliminary efficacy of [90Y]DOTA-biotin-avidin radiotherapy against non-muscle invasive bladder cancer.

• Authors : Alì, Alessandra¹; Leibowitz, Dev¹; Bhatt, Nikunj¹

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Feb2023, Vol. 50 Issue 3, p692-700. 9p. 1 Color Photograph, 1 Chart, 4 Graphs.

تفاصيل العنوان

Intraindividual comparison of [177Lu]Lu-DOTA-EB-TATE and [177Lu]Lu-DOTA-TOC.

• Authors : Hänscheid, Heribert¹ (AUTHOR) ; Hartrampf, Philipp E.¹ (AUTHOR); Schirbel, Andreas¹ (AUTHOR)

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2021, Vol. 48 Issue 8, p2566-2572. 7p. 1 Color Photograph, 1 Black and White Photograph, 4 Charts.

تفاصيل العنوان